Phase 3 Hypoparathyroidism Clinical Trials
2 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–2 of 2 trials
Recruiting
Phase 3
A Phase 3 Randomized Clinical Trial to Investigate the Safety and Efficacy of Palopegteriparatide at Doses Greater Than 30 μg/Day in Adult Participants With Hypoparathyroidism
HypoparathyroidismEndocrine System DiseasesParathyroid Diseases
Ascendis Pharma Bone Diseases A/S36 enrolled2 locationsNCT07081997
Recruiting
Phase 3
Autofluorescence and Indocyanine Green to Avoid Hypocalcemia After Thyroidectomy
Thyroid DiseaseHypoparathyroidism Postprocedural
Onze Lieve Vrouw Hospital300 enrolled1 locationNCT05117853